For large and small pharmaceutical companies alike; developing a new drug is fraught with risk. Patient-centric drug development and optimization is both a tool and a trend for drug development. By designing products with the patient in mind from the beginning of the process, pharmaceutical companies minimize the many risks they encounter on the path to market. Download this eBook to learn more about the strategies and technologies to minimize the risks of developing new drugs and ensuring they are safe, well-tolerated and available to the widest possible patient populations.
The nature and scope of clinical research has changed significantly over the past decade. Studies are more complex, globalized and patient-centric than ever. Yet, the processes used to package and ship study drugs to trial sites are stuck in an earlier era, depriving sponsors of clinical supply models with the flexibility, speed and efficiency their programs demand. Now, that may be about to change with the advent of demand led supply (DLS), a clinical supply model tailored to today’s trials.